Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans

To examine the efficacy of Lactobacillus gasseri OLL2716 (LG21) as a probiotic for Helicobacter pylori in humans, 31 subjects infected with the bacterium ingested yogurt containing LG21 daily for an 8 week period. The [13C]urea breath test and assays of serum pepsinogens revealed a significant impro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of antimicrobial chemotherapy 2001-05, Vol.47 (5), p.709-710
Hauptverfasser:	Sakamoto, Ichiko, Igarashi, Muneki, Kimura, Katsunori, Takagi, Atsushi, Miwa, Takeshi, Koga, Yasuhiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Female Helicobacter Infections - blood Helicobacter Infections - therapy Helicobacter pylori - physiology Humans Lactobacillus - physiology Male Medical sciences Middle Aged Pepsinogen A - blood Pepsinogen C - blood Pharmacology. Drug treatments Probiotics - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To examine the efficacy of Lactobacillus gasseri OLL2716 (LG21) as a probiotic for Helicobacter pylori in humans, 31 subjects infected with the bacterium ingested yogurt containing LG21 daily for an 8 week period. The [13C]urea breath test and assays of serum pepsinogens revealed a significant improvement following LG21 treatment. LG21 was thus determined to be effective in both suppressing H. pylori and reducing gastric mucosal inflammation.
ISSN:	0305-7453 1460-2091
DOI:	10.1093/jac/47.5.709